RAC 2.20% $1.78 race oncology ltd

Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-109

  1. 6,972 Posts.
    lightbulb Created with Sketch. 866
    science appears fine but nothing is a sure thing until given the tick after phase 3 trails at the end of the day… The new path way for heart protection has given RAC a new breathe of life!

    The thing that concerns me is the valuation by the market at the stage it is in….. I would consider buying at $1.20 or below

    All in my opinion
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.